This article reviews four of the most widely used peptides in longevity programs: BPC-157, TB-500, Ipamorelin, and MOTS-c, including mechanisms, applications, and supporting scientific literature
In much of the clinical research, TB-500 is described as systemic supportmeaning its often framed as a peptide that can influence broader recovery signaling rather than only localized tissue effects
Physicians prescribe GLP-1 agonists such as semaglutide, liraglutide, tirzepatide, and dulaglutide for the management of type 2 diabetes mellitus and weight management for obese patients
Mounjaro is injected under the skin in specific areas of the body
Some preclinical and emerging research suggests that GLP-1 may have indirect effects on mood and behaviour through potential influence on: Hypothalamic circuits that regulate both feeding behaviour and emotional responses Reward pathways in the brain, potentially affecting dopaminergic systems Inflammatory markers and metabolic health, which may influence mental wellbeing These potential indirect pathways are still being investigated, and their clinical relevance in humans remains unclear
To ensure proper handling, the user should follow the guidelines provided by their institution or healthcare professional